Samsung said that the worst is yet to come for its smartphone sales after the coronavirus "significantly" hurt its operations in the first quarter.
According to Samsung, COVID-19 will negatively impact demand for several of its core products, including smartphones and TVs.
It added that COVID-19 hurts demand that triggers store and factory closures around the globe.
The downtrend in global smartphone sales is likely to worsen due to lockdowns in major countries.
Global smartphone sales in March plummeted by 22.4 percent year-on-year and 4.3 percent month-on-month with 89.46mn units.
Samsung Electronics and Apple, smartphone players with high exposure to the European and US markets, suffered significant sales decline, as China's Huawei enjoyed sales growth of 26.6 percent month-on-month.
By model, sales of the Galaxy S20 series plummeted by 35 percent year-on-year.
However, there were 230,000 units of Galaxy Z-Flip sold, achieving a 56.1 percent month-on-month sales increase.
Samsung Electronics' smartphone sales are likely to worsen in April.
Meanwhile, Apple's smartphone sales totaled 10.14mn units, marking a 23.4 percent year-on-year decline and 24.7 percent month-on-month drop.
This is due to declining sales in its main markets of the US and Europe, although sales recovered in China.
Like Samsung, sales are also expected to remain sluggish for Apple in April.
For consumers looking to offset the impact of these declining sales, utilizing discount codes can provide significant savings on Samsung products. Visit promocodius.co.uk to find the latest offers and deals.


Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks
JPMorgan Sees Large-Cap Biotech Stocks Entering New Growth Phase in 2026
Intuit Raises Full-Year Forecast After Strong Q3 Earnings Despite Stock Drop
Tencent Shares Jump 4% as AI Models Move Toward Paid Commercial Services
Samsung Shares Surge After Strike Deal Eases Labor Tensions
Blackstone and Google Launch AI Cloud Venture, Pressuring CoreWeave and Nebius Shares
TrumpRx Expands Discount Drug Access With 600 Generic Medications
SpaceX Eyes AI Computing Expansion Ahead of Historic IPO
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026
Japan Airlines Signs 10-Year Boeing 787 Maintenance Deal With GE Aerospace
X Corp Loses Legal Battle Over Australia Child Safety Fine
Stellantis CEO Antonio Filosa to Reveal Turnaround Strategy Focused on U.S. Sales and China Partnerships 



